Skip to main content
Molecule Holdings Inc. logo

Molecule Holdings Inc. — Investor Relations & Filings

Ticker · MLCL ISIN · CA60855E1097 LEI · 529900E2EB85616O9A84 CSE Manufacturing
Open in API
Filings indexed 376 across all filing types
Latest filing 2021-05-06 Regulatory Filings
Country CA Canada
Listing CSE MLCL

About Molecule Holdings Inc.

https://molecule.ca/

Molecule Holdings Inc. is a licensed producer specializing in the cannabis beverages sector. The company focuses on the production, packaging, and distribution of a portfolio of quality crafted branded cannabis beverages (CIBs). Recognized for its innovation, Molecule also serves as a comprehensive contract manufacturer and co-packer for the consumer packaged goods market. The company provides essential infrastructure, technology, know-how, and licensing capabilities, enabling craft producers to develop and market various consumable cannabis products, including beverages and edibles. Molecule is noted for being an early entrant, having been the first small-cap company fully dedicated to cannabis beverages to receive its specific processing license.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from Atico Mining Corporation reporting on exploration drilling results at the La Plata VMS project in Ecuador. It contains detailed assay results, geological descriptions, and exploration updates. There is no indication that this is a financial report, earnings release, or regulatory filing. It is not an annual or interim report, nor a management discussion or investor presentation. The content focuses on exploration results and technical data rather than financial performance or corporate governance. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement about exploration results that does not fit into other specific categories.
2021-05-06 English
News release - English.pdf
Regulatory Filings
2021-04-28 English
News release - English.pdf
AGM Information Classification · 90% confidence The document is a corporate update press release from Molecule Holdings Inc. dated April 26, 2021. It discusses product launches, an invitation to present at a virtual event, and importantly, it includes a reminder about the upcoming Annual General Meeting (AGM) scheduled for April 30, 2021. The document does not contain any financial statements, detailed financial performance data, or comprehensive report content. It is primarily an announcement and update, including an AGM reminder, but not the AGM materials themselves. Given the content and length (4785 characters), it is not a full Annual Report or Interim Report. It is also not a voting results announcement or a proxy solicitation. The document fits best as an AGM Information type, as it relates to the AGM event and provides related corporate updates and reminders for shareholders.
2021-04-26 English
Management information circular - English.pdf
Regulatory Filings
2021-04-13 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV2 Certification of Interim Filings for a venture issuer, signed by the CFO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended January 31, 2021. The document is primarily an officer certification letter and does not contain actual financial statements or substantive financial data. It explicitly states it is a certification and does not include representations about internal controls. According to the CERTIFICATION RULE, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (2949 characters), consistent with a certification letter rather than a full report.
2021-04-01 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a FORM 52-109FV2 Certification of Interim Filings for a venture issuer, signed by the CEO. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended January 31, 2021. The text explicitly states it is a certification related to interim filings, not the filings themselves. The document is short (2970 characters) and primarily an officer certification letter, not containing actual financial data or substantive financial analysis. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as an Interim Report (IR).
2021-04-01 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.